Target intelligence / Profile preview

Cellular DNA and nucleoproteins (DNA/NP)

Target
DNA/NP
Molecular classification
Nucleic acid, Nucleoprotein, Histone modification, Other
01

Overview

Cellular DNA and nucleoproteins represent the collective genetic material and the structural proteins, such as histones, that package it within the nucleus. DNA serves as the essential template for heredity, directing protein synthesis through transcription and ensuring genetic continuity through replication (NIH, 2023). Nucleoproteins play a critical role in maintaining the stability of the genome and regulating gene expression by controlling chromatin density. In the context of oncology, DNA is a major therapeutic target; many chemotherapy agents exert their effects by forming covalent adducts or intercalating between base pairs to disrupt cell division (StatPearls, 2024). These interactions lead to the activation of DNA damage checkpoints and, if the damage is irreparable, the induction of apoptosis. Beyond cancer, nucleoproteins are also targeted in certain viral infections and are involved in the pathogenesis of autoimmune conditions like systemic lupus erythematosus (PubMed, 2022). Despite their efficacy, drugs targeting these structures often lack specificity for malignant cells, resulting in significant systemic toxicities.

Other names
Deoxyribonucleic acidChromatinGenomic DNANucleoprotein complexNuclear DNA
02

Mechanism of action

Covalent binding to DNA bases (alkylation), insertion between planar base pairs (intercalation), formation of intra- and inter-strand cross-links, and induction of oxidative DNA cleavage.

03

Biological functions

DNA replicationTranscriptionCell cycleCell proliferationCell deathOther
04

Disease associations

CancerInfectionAutoimmune diseaseOther
05

Safety considerations

MyelosuppressionSecondary malignanciesNephrotoxicityCardiotoxicityTeratogenicityMutagenicity
06

Interacting drugs

Cisplatin

8 more in the full profile.

07

Biomarkers

gamma-H2AXMicrosatellite instability (MSI)Tumor mutational burden (TMB)DNA adductsBRCA1/2 mutation status

Beyond the preview

Go deeper on Cellular DNA and nucleoproteins (DNA/NP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular DNA and nucleoproteins (DNA/NP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call